Answers are grounded in this paper and cite their sources.
Radiation therapy is one of the most common cancer treatment methods, with approximately 50–60% of cancer patients receiving it. Despite the outstanding advances in the field of its application, especially once technology is concerned, significant obstacles still need to be overcome. The main problems of radiation therapy include tumor resistance and damage to healthy tissues, which leads to negative consequences and inadequate tumor control. Manipulations with the microRNA family is considered to be a promising approach for overcoming these limitations. The purpose of the review is to analyze the literature data on the role of microRNAs in the regulation of resistance to radiation therapy in human tumors, as well as to evaluate the possibility of manipulations with microRNAs to overcome radioresistance. The evaluation of the articles was carried out in accordance with PRISMA guidelines. The search retrieved 2153 publications. The search queries included the following keywords and their combinations: “microRNA”, “cancer”, “oncological diseases”, “malignant neoplasms”, “radiation therapy”, “radioresistance”. The analysis of the literature data shows that microRNAs will play an important role in radiation oncology in the future. The use of microRNAs is likely to be the basis for the development of specialized therapies that will increase radiosensitivity, as well as for predicting the response to radiation therapy. Early studies have shown that microRNAs can be used as biomarkers for predicting and monitoring therapy, providing a more accurate and personalized approach to patient management.
No takes yet. Share an insight, caveat, or question.
Gamidova et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: